Surrozen (SRZN) Competitors $10.56 +0.69 (+6.99%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SRZN vs. PLX, SAVA, IVA, EDIT, ALGS, ABOS, MGX, LPTX, TARA, and INMBShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include Protalix BioTherapeutics (PLX), Cassava Sciences (SAVA), Inventiva (IVA), Editas Medicine (EDIT), Aligos Therapeutics (ALGS), Acumen Pharmaceuticals (ABOS), Metagenomi (MGX), Leap Therapeutics (LPTX), Protara Therapeutics (TARA), and INmune Bio (INMB). These companies are all part of the "pharmaceutical products" industry. Surrozen vs. Protalix BioTherapeutics Cassava Sciences Inventiva Editas Medicine Aligos Therapeutics Acumen Pharmaceuticals Metagenomi Leap Therapeutics Protara Therapeutics INmune Bio Surrozen (NASDAQ:SRZN) and Protalix BioTherapeutics (NYSE:PLX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, community ranking, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations. Is SRZN or PLX more profitable? Surrozen has a net margin of 0.00% compared to Protalix BioTherapeutics' net margin of -21.03%. Protalix BioTherapeutics' return on equity of -30.89% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets SurrozenN/A -120.51% -54.68% Protalix BioTherapeutics -21.03%-30.89%-11.74% Do insiders and institutionals have more ownership in SRZN or PLX? 66.6% of Surrozen shares are held by institutional investors. Comparatively, 16.5% of Protalix BioTherapeutics shares are held by institutional investors. 43.5% of Surrozen shares are held by insiders. Comparatively, 6.3% of Protalix BioTherapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to SRZN or PLX? In the previous week, Protalix BioTherapeutics had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for Protalix BioTherapeutics and 0 mentions for Surrozen. Surrozen's average media sentiment score of 0.00 equaled Protalix BioTherapeutics'average media sentiment score. Company Overall Sentiment Surrozen Neutral Protalix BioTherapeutics Neutral Which has stronger earnings and valuation, SRZN or PLX? Protalix BioTherapeutics has higher revenue and earnings than Surrozen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurrozen$10M3.43-$43.04MN/AN/AProtalix BioTherapeutics$45.67M2.84$8.31M-$0.13-13.54 Which has more risk & volatility, SRZN or PLX? Surrozen has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Protalix BioTherapeutics has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Does the MarketBeat Community favor SRZN or PLX? Protalix BioTherapeutics received 4 more outperform votes than Surrozen when rated by MarketBeat users. Likewise, 70.00% of users gave Protalix BioTherapeutics an outperform vote while only 16.67% of users gave Surrozen an outperform vote. CompanyUnderperformOutperformSurrozenOutperform Votes316.67%Underperform Votes1583.33% Protalix BioTherapeuticsOutperform Votes770.00% Underperform Votes330.00% SummaryProtalix BioTherapeutics beats Surrozen on 7 of the 12 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$34.32M$2.94B$5.12B$9.07BDividend YieldN/A1.90%4.91%4.22%P/E RatioN/A46.7391.3417.19Price / Sales3.43411.851,117.70116.80Price / CashN/A182.1042.6437.86Price / Book0.573.894.794.78Net Income-$43.04M-$42.21M$120.07M$225.60M7 Day Performance7.21%-2.14%-1.90%-1.23%1 Month Performance13.55%4.21%11.45%3.37%1 Year Performance34.01%18.40%30.63%16.58% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen1.0933 of 5 stars$10.56+7.0%N/A+32.3%$34.32M$10M0.0042PLXProtalix BioTherapeuticsN/A$1.75-2.8%N/A+2.9%$128.85M$65.49M-13.81200SAVACassava Sciences4.3986 of 5 stars$2.66-3.3%$111.50+4,091.7%-88.1%$127.97MN/A-1.9930News CoverageGap DownIVAInventiva3.124 of 5 stars$2.39-2.4%$13.25+454.4%-45.3%$125.42M$15.62M0.00100EDITEditas Medicine4.3804 of 5 stars$1.48+2.8%$7.00+373.0%-87.2%$122.17M$61.76M-0.58230High Trading VolumeALGSAligos Therapeutics3.9799 of 5 stars$33.66-1.2%$75.00+122.8%+161.2%$120.77M$6.00M-2.5690News CoverageGap DownHigh Trading VolumeABOSAcumen Pharmaceuticals3.1587 of 5 stars$1.97-3.0%$9.33+373.8%-39.9%$118.36MN/A-1.4751Short Interest ↓News CoveragePositive NewsMGXMetagenomi2.1336 of 5 stars$3.11-4.3%$16.67+436.8%N/A$116.20M$55.08M0.00236High Trading VolumeLPTXLeap Therapeutics1.2946 of 5 stars$3.01+2.0%$7.50+149.2%-1.0%$115.34M$1.50M-1.5340Positive NewsGap DownTARAProtara Therapeutics2.3557 of 5 stars$5.53-7.5%$22.67+309.9%+196.2%$114.08MN/A-1.8830INMBINmune Bio1.4803 of 5 stars$5.08+6.9%$20.00+293.7%-55.7%$112.63M$42,000.00-2.3310 Related Companies and Tools Related Companies PLX Competitors SAVA Competitors IVA Competitors EDIT Competitors ALGS Competitors ABOS Competitors MGX Competitors LPTX Competitors TARA Competitors INMB Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRZN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRZN Stock Alerts